Article at THE DOCTOR Magazine: NGS PLATFORM - ITS CONTRIBUTION TO CLINICAL PRACTICE


Ποιά η συμβολή της πλατφόρμας NGS στη μάχη κατά του καρκίνου

Article in "The Doctor" magazine by members of the scientific research team of hereditary cancer of Genekor Medical.

They write:


Konstantinos Agiannitopoulos Molecular Biologist, MSc, PhD

&

Despina Apostolopoulou Molecular Biologist, MSc, PhD




Article at THE DOCTOR Magazine: NGS PLATFORM - ITS CONTRIBUTION TO CLINICAL PRACTICE

NGS PLATFORM - ITS CONTRIBUTION TO CLINICAL PRACTICE  

In recent years, Next Generation Sequencing (NGS) technology
has been actively introduced into clinical practice,
playing an essential role in understanding
the genetics of many diseases, such as cancer.

NGS platforms include 3 main categories: 1) targeted gene panels,
2) sequencing of all exons, ie the regions of the genome encoding proteins
(Whole Exome Sequencing-WES) and 3) sequencing of
the entire genome (Whole W Genome Sequencing) ).

With the use of NGS it is possible to detect both mutations
in genes associated with hereditary cancer and the analysis of
the molecular profile of the tumor (somatic mutations).

For more information visit:
https://www.genekor.com/en/about-genekor/

30.08.2021
Change cookies consent Revoke cookies consent